Charles Schwab Investment Management Inc. Sells 91,984 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Charles Schwab Investment Management Inc. lowered its position in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 7.5% during the fourth quarter, Holdings Channel.com reports. The firm owned 1,138,380 shares of the company’s stock after selling 91,984 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in AdaptHealth were worth $10,837,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. Intech Investment Management LLC increased its stake in AdaptHealth by 223.2% during the 3rd quarter. Intech Investment Management LLC now owns 59,650 shares of the company’s stock worth $670,000 after acquiring an additional 41,196 shares during the period. Victory Capital Management Inc. increased its stake in AdaptHealth by 727.4% during the 3rd quarter. Victory Capital Management Inc. now owns 141,507 shares of the company’s stock worth $1,589,000 after acquiring an additional 124,404 shares during the period. Barclays PLC increased its stake in AdaptHealth by 361.3% during the 3rd quarter. Barclays PLC now owns 181,240 shares of the company’s stock worth $2,034,000 after acquiring an additional 141,949 shares during the period. Principal Financial Group Inc. increased its stake in AdaptHealth by 39.7% during the 3rd quarter. Principal Financial Group Inc. now owns 543,744 shares of the company’s stock worth $6,106,000 after acquiring an additional 154,434 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in AdaptHealth by 73.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 191,833 shares of the company’s stock worth $2,154,000 after acquiring an additional 81,097 shares during the period. Institutional investors own 82.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have commented on AHCO. UBS Group lowered their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Thursday, February 13th. Royal Bank of Canada raised their price objective on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Robert W. Baird raised their price objective on AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research note on Thursday, February 27th. Canaccord Genuity Group raised their target price on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Finally, Truist Financial raised their target price on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a report on Wednesday, February 26th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of $13.80.

AdaptHealth Trading Down 0.2 %

Shares of AHCO stock opened at $9.99 on Friday. The stock’s fifty day moving average price is $10.01 and its two-hundred day moving average price is $10.19. The company has a market cap of $1.35 billion, a PE ratio of -6.05, a P/E/G ratio of 1.08 and a beta of 1.30. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.